<DOC>
	<DOCNO>NCT00416689</DOCNO>
	<brief_summary>RATIONALE : Understanding nausea vomit cause chemotherapy effect patient 's treatment decision may help doctor plan good cancer treatment may help patient live comfortably . PURPOSE : This clinical trial study nausea vomit patient receive chemotherapy breast cancer lung cancer .</brief_summary>
	<brief_title>Nausea Vomiting Patients Who Are Receiving Chemotherapy Breast Cancer Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine contribution nausea vomit overall importance current state health patient breast lung cancer undergo chemotherapy . - Determine average importance various emetic scenario patient . - Compare importance specific level chemotherapy-induced nausea vomiting , define Standard Gamble v Morrow Assessment Nausea Emesis . - Determine feasibility use Standard Gamble technique patient currently undergo chemotherapy . OUTLINE : This multicenter study . Patients stratify accord history chemotherapy-induced nausea vomiting ( yes v ) . Patients undergo structure interview 1 hour train interviewer least 2½ week initiation recent course chemotherapy new course administer . Patients complete Functional Assessment Cancer Therapy-General questionnaire Morrow Assessment Nausea Emesis questionnaire interview . The trained interviewer also administer Standard Gamble exercise interview , patient instruct imagine various amount nausea vomit current state nausea vomiting , rank importance . They ask answer question whether would choose accept current ( imagined real ) state nausea vomit receive medication would result ( various probability ) either perfect health 2 year immediate death .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis breast cancer lung cancer Must undergo chemotherapy course last 36 week AND meet follow criterion : Completed ≥ 1 course ≥ 1 additional course plan At least 2½ week since initiation recent course chemotherapy PATIENT CHARACTERISTICS : Common Toxicity Criteria performance status 02 Must command write and/or spoken English PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>nausea vomit</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
</DOC>